Catalyst Wire Dossier Catalyst Wire Dossier

MB-CART20.1

· Miltenyi Biomedicine GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB-CART20.1, covering 2024-05-16 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: MB-CART20.1 Melanoma [EARLY_Phase 1]

See pricing